| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT07630233 A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… |
Enrollment increased: 43 -> 53 participants |
| 2026-07-21 | NCT07630233 A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… |
Trial arms changed: 3 -> 4 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07648225 | UBT251 Injection Phase Ⅲ Study (Overweight or Obesity) | Obesity & Overweight | Not Yet Recruiting |
| NCT07653477 | Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate… | Type 2 Diabetes | Not Yet Recruiting |
| NCT07659574 | Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With… | Type 2 Diabetes | Not Yet Recruiting |
| Phase 2 | |||
| NCT07145151 | A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis… | Metabolic Dysfunction-associated Steatohepatitis (MASH) | Recruiting |
| NCT07134335 | UBT251 Injection Phase II Clinical Study (CKD) | Obesity & Overweight | Recruiting |
| Phase 1 | |||
| NCT07630233 | A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… | Type 2 Diabetes Mellitus (T2DM) | Not Yet Recruiting |